FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
Oliveira, M, Saura, C, Nuciforo, P, Calvo, I, Andersen, J, Passos-Coelho, J L, Gil Gil, M, Bermejo, B, Patt, D A, Ciruelos, E, de la Peña, L, Xu, N, Wongchenko, M, Shi, Z, Singel, S M, Isakoff, S JJournal:
Annals of Oncology
DOI:
10.1093/annonc/mdz177
Date:
May, 2019
File:
PDF, 1.07 MB
2019